Nucleobase catalysts for the enzymatic activation of 8-oxoguanine DNA glycosylase 1
Bifunctional DNA glycosylases employ an active site lysine or the N-terminus to form a Schiff base with an abasic (AP) site base excision repair intermediate. For 8-oxoguanine DNA glycosylase 1 (OGG1), cleaving this reversible structure is the rate-determining step in the initiation of 8-oxoguanine (8-oxoG) repair in DNA. Evolution has led OGG1 to use a product-assisted catalysis approach, where the excised 8-oxoG acts as a Brønsted base for cleavage of a Schiff base intermediate. However, the physicochemical properties of 8-oxoG significantly limit the inherent enzymatic turnover leading to a weak, cellularly absent, AP lyase activity. We hypothesized that chemical synthesis of purine analogues enables access to complex structures that are suitable as product-like catalysts. Herein, the nucleobase landscape is profiled for its potential to increase OGG1 Schiff base cleavage. 8-Substituted 6-thioguanines emerge as potent and selective scaffolds enabling OGG1 to cleave AP sites opposite any canonical nucleobase by β-elimination. This effectively broadens the enzymatic substrate scope of OGG1, shaping a complete, artificial AP-lyase function. In addition, a second class of compounds, 6-substituted pyrazolo-[3,4-<i>d</i>]-pyrimidines, stimulate OGG1 function at high pH, while thioguanines govern enzymatic control at acidic pH. This enables up to 20-fold increased enzyme turnover and a <i>de novo</i> OGG1 β-elimination in conditions commonly not tolerated. The tool compounds employed here are non-toxic in cells and stimulate the repair of AP sites through a natural, APE1 dependent pathway, as opposed to previously reported β,δ-lyase stimulator TH10785.
Authors
- Ann‐Sofie Jemth (ORCID: https://orcid.org/0000-0002-7550-1833)
- Stefan Knapp (ORCID: https://orcid.org/0000-0001-5995-6494)
- Evert J. Homan (ORCID: https://orcid.org/0000-0002-9057-1848)
- Alicia del Prado (ORCID: https://orcid.org/0000-0002-5480-0367)
- Kaixin Zhou (ORCID: https://orcid.org/0000-0002-4751-7248)
- Miguel de Vega (ORCID: https://orcid.org/0000-0003-1285-7549)
- Marek Varga (ORCID: https://orcid.org/0000-0002-9685-8145)
- Emily C. Hank (ORCID: https://orcid.org/0000-0002-3777-4697)
- Thomas Helleday (ORCID: https://orcid.org/0000-0002-7384-092X)
- Pål Stenmark (ORCID: https://orcid.org/0000-0003-4777-3417)
- Josephine Stewart
- Nicholas D. D’Arcy-Evans (ORCID: https://orcid.org/0009-0004-3503-4726)
- Emma Rose Scaletti (ORCID: https://orcid.org/0000-0002-8741-8981)
- Olov A. Wallner (ORCID: https://orcid.org/0000-0002-6481-237X)
- Alice Eddershaw (ORCID: https://orcid.org/0000-0002-8381-4135)
- Holly Dawson
- Leandro Sastre (ORCID: https://orcid.org/0000-0003-3613-5938)
- Maurice Michel (ORCID: https://orcid.org/0000-0003-3261-2493)
- Maeve Long (ORCID: https://orcid.org/0000-0001-5146-0750)
- Carlos Benitéz‐Buelga (ORCID: https://orcid.org/0009-0006-3097-1109)
- Martin Scobie (ORCID: https://orcid.org/0000-0002-7073-8495)
- Sara Košenina (ORCID: https://orcid.org/0000-0001-7893-0249)
- Ingrid Almlöf
- Elisée Wiita
- Andreas Krämer (ORCID: https://orcid.org/0000-0003-3294-2660)
- Florian Ortis (ORCID: https://orcid.org/0000-0002-0458-5187)
- Patricia Calvo (ORCID: https://orcid.org/0000-0001-7240-7115)
- Adam Dickey
- Mikhael E. Astorga
- Liuzhen Meng
- Mario Kehler
- Karen Nierlin
Institutions
- Goethe University Frankfurt (DE)
- Karolinska University Hospital (SE)
- Stockholm University (SE)
- Lund University (SE)
- Instituto de Salud Carlos III (ES)
- Weston Park Cancer Centre (GB)
- Structural Genomics Consortium (CA)
- Karolinska Institutet (SE)
- Instituto de Investigaciones Biomédicas Sols-Morreale (ES)
- Centro de Biología Molecular Severo Ochoa (ES)
- Instituto de Investigación de Enfermedades Raras (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- RSC Chemical Biology
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1039/d4cb00323c
- Primary Topic
- DNA Repair Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- McGill University
- Diamond Light Source
- European Federation of Pharmaceutical Industries and Associations
- European Commission
- Cancerfonden
- Karolinska Institutet
- Novo Nordisk
- Kungliga Tekniska Högskolan
- Vetenskapsrådet
- Goethe-Universität Frankfurt am Main
- Novo Nordisk Fonden
- Instituto de Salud Carlos III
- Agencia Estatal de Investigación